Entry |
|
Name |
Pirlindole hydrochloride; Implementor (TN) |
Formula |
C15H18N2. HCl
|
Exact mass |
262.1237
|
Mol weight |
262.78
|
Structure |

|
Simcomp |
|
Class |
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01558 Monoamine oxidase A inhibitor
|
Remark |
|
Efficacy |
Antidepressant, Monoamine oxidase A (MAO-A) inhibitor |
Target |
|
Pathway |
hsa00260 | Glycine, serine and threonine metabolism |
hsa00330 | Arginine and proline metabolism |
hsa00982 | Drug metabolism - cytochrome P450 |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01558 Monoamine oxidase A inhibitor
DG01277 Pirlindole
D08393 Pirlindole hydrochloride
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Amine oxidases
MAOA
D08393 Pirlindole hydrochloride
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01558 Monoamine oxidase A inhibitor
DG01277 Pirlindole
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 18
1 C8y C 19.3523 -22.0898
2 C8x C 19.3523 -23.4874
3 C8x C 20.5402 -24.1861
4 C8y C 21.7281 -23.4874
5 C8y C 21.7281 -22.0898
6 C8x C 20.5402 -21.3911
7 N4y N 23.0558 -23.9066
8 C8y C 23.8943 -22.7886
9 C8y C 23.0558 -21.6706
10 C1x C 23.8248 -25.3044
11 C1x C 25.2924 -25.3042
12 N1x N 25.8509 -24.0461
13 C1y C 25.2919 -22.7884
14 C1x C 26.0605 -21.6703
15 C1x C 25.5015 -20.3425
16 C1x C 23.8940 -20.3428
17 C1a C 18.1644 -21.3911
18 X Cl 29.0652 -22.9982
BOND 20
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 2
10 5 9 1
11 7 10 1
12 10 11 1
13 11 12 1
14 12 13 1
15 8 13 1
16 13 14 1
17 14 15 1
18 15 16 1
19 16 9 1
20 1 17 1
|